New hope for rare ovarian cancer: immunotherapy drug tested in small trial
Disease control
Ongoing
This study tests the drug pembrolizumab in 21 women with a rare and advanced form of ovarian cancer called squamous cell carcinoma. The goal is to see if the drug can shrink tumors or slow the cancer's growth. Participants receive the drug intravenously, and the study tracks how …
Phase: PHASE2 • Sponsor: Niigata University Medical & Dental Hospital • Aim: Disease control
Last updated Jun 08, 2026 13:05 UTC